The baseline characteristics of included studies.

Note: ①/②/③represented retrospective cohort study, prospective cohort study, case-control study, respectively.mo = months, yr = years.ESRD = end stage renal disease,CKD = chronic kidney disease,GBCAs = gadolinium-basedcontrast agents, NSF = nephrogenic systemic fibrosis, NA = not available, Gd-DOTA = meglumine gadoterate‡88.6% MR examinations were performed with gadodiamide (Ominscan), 11.4% were performed with Multihance, Magnevist,etc.‡‡76% received gadoterate†Seven types of GBCAs were used in MR examinations* Five types of GBCAs¶ Gadodiamide, gadopentetate dimeglumine, gadobutrol, etc.**Seven types of GBCAs$ Positive association was found between GBCAs and NSF♯ Insufficiency evidence showed GBCAs was associated with the development of NSF.The baseline characteristics of included studies.